EQT AB
EQT AB (publ) is a global private equity & venture capital firm specializing in private capital and real asset segments. The firm seeks to invest in seed, startup, turnaround, middle market, mature, early venture, emerging growth, mid venture, late venture, distressed/vulture, loan, secondary (direct) investments. The firm seeks to invest through growth, buyout and recapitalization in companies. … Read more
EQT AB (0AAZ) - Net Assets
Latest net assets as of : Skr- SEK
Based on the latest financial reports, EQT AB (0AAZ) has net assets worth Skr- SEK as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr-) and total liabilities (Skr-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
EQT AB - Net Assets Trend (None–None)
This chart illustrates how EQT AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EQT AB (None–None)
The table below shows the annual net assets of EQT AB from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to EQT AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
EQT AB Competitors by Market Cap
The table below lists competitors of EQT AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PetroChina Co Ltd Class H
PINK:PCCYF
|
$23.30 Billion |
|
Mitsui Fudosan Co. Ltd
PINK:MTSFF
|
$23.31 Billion |
|
Erste Group Bank AG
PINK:EBKOF
|
$23.33 Billion |
|
Airbus Group NV
PINK:EADSY
|
$23.34 Billion |
|
KBC Group NV
PINK:KBCSF
|
$23.29 Billion |
|
Capgemini SE
PINK:CAPMF
|
$23.23 Billion |
|
Evolution Mining Limited
PINK:EVMNY
|
$23.20 Billion |
|
Church & Dwight Company Inc
NYSE:CHD
|
$23.18 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EQT AB's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares EQT AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently EQT AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares EQT AB's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EQT AB (0AAZ) | Skr- | N/A | N/A | $23.30 Billion |
| Nyfosa AB (0A0K) | $3.48 Billion | 34.90% | 2.92x | $966.63 Million |
| Tethys Oil AB (0A1V) | $56.23 Million | 21.07% | 0.01x | $122.95 Million |
| High Templar Tech Limited (0A2T) | $11.29 Billion | 0.81% | 0.10x | $258.25 Million |
| Strategy Inc (0A7O) | $361.50 Million | 1.39% | 0.55x | $38.08 Billion |
| NACON SASU (0A9N) | $210.72 Million | 8.63% | 0.51x | $7.82 Million |
| Antin Infrastructure Partners (0AA5) | $32.26 Million | 152.50% | 1.23x | $545.92 Million |
| Truecaller AB Series B (0AA7) | $1.51 Billion | 34.81% | 0.30x | $277.14 Million |
| Brockhaus Technologies AG (0AAW) | $315.34 Million | 15.55% | 1.46x | $74.17 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $-10.19 Million | 0.00% | 0.00x | $71.96 Million |
| Kalray S.A. (0ABT) | $39.07 Million | -59.55% | 1.26x | $33.84 Million |